MRL-SABR for oligometastatic disease
MRL-SABR (magnetic resonance linac combined with stereotactic ablative radiotherapy) represents a paradigm shift in the management of oligometastatic disease, offering a targeted and minimally invasive treatment option with the potential for improved outcomes. Here, Dr Sathish Harinarayanan, renowned consultant clinical oncologist, provides an expert insight into the intricacies of MRL-SABR.